0001209191-14-044780.txt : 20140701 0001209191-14-044780.hdr.sgml : 20140701 20140701175028 ACCESSION NUMBER: 0001209191-14-044780 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20140701 FILED AS OF DATE: 20140701 DATE AS OF CHANGE: 20140701 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GLOBEIMMUNE INC CENTRAL INDEX KEY: 0001245104 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 841353925 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1450 INFINITE DRIVE CITY: LOUISVILLE STATE: CO ZIP: 80027 BUSINESS PHONE: 3036252744 MAIL ADDRESS: STREET 1: 1450 INFINITE DRIVE CITY: LOUISVILLE STATE: CO ZIP: 80027 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Christoffersen Kirk A CENTRAL INDEX KEY: 0001600227 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35642 FILM NUMBER: 14953717 MAIL ADDRESS: STREET 1: 1450 INFINITE DRIVE CITY: LOUISVILLE STATE: CO ZIP: 80027 3 1 doc3.xml FORM 3 SUBMISSION X0206 3 2014-07-01 0 0001245104 GLOBEIMMUNE INC GBIM 0001600227 Christoffersen Kirk A C/O GLOBEIMMUNE, INC. 1450 INFINITE DRIVE LOUISVILLE CO 80027 0 1 0 0 VP, Corporate Development Stock Option (right to buy) 4.71 2014-12-15 Common Stock 2389 D Stock Option (right to buy) 4.71 2016-05-08 Common Stock 1592 D Stock Option (right to buy) 5.02 2017-05-02 Common Stock 410 D Stock Option (right to buy) 5.96 2018-03-19 Common Stock 2561 D Stock Option (right to buy) 8.48 2019-09-23 Common Stock 860 D Stock Option (right to buy) 12.56 2020-02-01 Common Stock 1139 D Stock Option (right to buy) 10.04 2021-03-16 Common Stock 473 D Stock Option (right to buy) 18.21 2022-03-27 Common Stock 269 D Stock Option (right to buy) 15.07 2024-03-12 Common Stock 7279 D Fully vested Grant to the Reporting Person of a stock option under the Issuer's 2002 Stock Incentive Plan (the "Plan"). The option vests over a four-year period, with 25% of such option vesting on November 30, 2011 and the remaining 75% of such option vesting in equal monthly installments over the next 36 months, provided that at the relevant vesting dates the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan. The option expires ten years after the date of grant. Grant to the Reporting Person of a stock option under the Plan. The option vests over a four-year period, with 25% of such option vesting on December 7, 2012 and the remaining 75% of such option vesting in equal monthly installments over the next 36 months, provided that at the relevant vesting dates the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan. The option expires ten years after the date of grant. Grant to the Reporting Person of a stock option under the Plan. The option vests over a four-year period, with 25% of such option vesting on January 1, 2015 and the remaining 75% of such option vesting in equal monthly installments over the next 36 months, provided that at the relevant vesting dates the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan. The option expires ten years after the date of grant. Attachment: Exhibit 24 - Power of Attorney /s/ Kirk A. Christoffersen 2014-07-01 EX-24 2 attachment1.htm EX-24 DOCUMENT

                                                                     Exhibit 24

                                POWER OF ATTORNEY

        Know all by these presents that the undersigned hereby constitutes and
appoints each of Timothy C. Rodell, C. Jeffrey Dekker, Brent D. Fassett and
Matthew P. Dubofsky, signing individually, the undersigned's true and lawful
attorneys-in fact and agents to:

                (1)     execute for and on behalf of the undersigned, an
        officer, director or holder of 10% of more of a registered class of
        securities of GlobeImmune, Inc. (the "Company"), Forms 3, 4 and 5 in
        accordance with Section 16(a) of the Securities Exchange Act of 1934, as
        amended (the "Exchange Act") and the rules thereunder;

                (2)     do and perform any and all acts for and on behalf of the
        undersigned that may be necessary or desirable to complete and execute
        such Forms 3, 4 or 5, complete and execute any amendment or amendments
        thereto, and timely file such forms or amendments with the United States
        Securities and Exchange Commission and any stock exchange or similar
        authority; and

                (3)     take any other action of any nature whatsoever in
        connection with the foregoing that, in the opinion of such
        attorney-in-fact, may be of benefit, in the best interest of, or legally
        required by, the undersigned, it being understood that the documents
        executed by such attorney-in-fact on behalf of the undersigned pursuant
        to this Power of Attorney shall be in such form and shall contain such
        terms and conditions as such attorney-in-fact may approve in such
        attorney-in-fact's discretion.

        The undersigned hereby grants to each such attorney-in-fact full power
and authority to do and perform any and every act and thing whatsoever
requisite, necessary, or proper to be done in the exercise of any of the rights
and powers herein granted, as fully to all intents and purposes as the
undersigned might or could do if personally present, with full power of
substitution or revocation, hereby ratifying and confirming all that such
attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall
lawfully do or cause to be done by virtue of this power of attorney and the
rights and powers herein granted. The undersigned acknowledges that the
foregoing attorneys-in-fact, in serving in such capacity at the request of the
undersigned, are not assuming, nor is the Company assuming, any of the
undersigned's responsibilities to comply with Section 16 of the Exchange Act.

        This Power of Attorney shall remain in full force and effect until the
earliest to occur of (a) the undersigned is no longer required to file Forms 3,
4 and 5 with respect to the undersigned's holdings of and transactions in
securities issued by the Company, (b) revocation by the undersigned in a signed
writing delivered to the foregoing attorneys-in-fact or (c) as to any
attorney-in-fact individually, until such attorney-in-fact shall no longer be
employed by the Company or Cooley LLP, as applicable.

        IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to
be executed as of this 1st day of July, 2014.

                                        /s/ Kirk A. Christoffersen
                                        ----------------------------------------
                                        Kirk A. Christoffersen